Literature DB >> 16998247

Long-term survival in metastatic pancreatic cancer. A case report and review of the literature.

Gian Paolo Spinelli1, Angelo Zullo, Adriana Romiti, Marisa Di Seri, Federica Tomao, Evelina Miele, Bruno Spalletta, Annarita Eramo, Cesare Hassan, Silverio Tomao.   

Abstract

CONTEXT: Pancreatic cancer still remains an incurable disease. The survival rate of patients in all stages of the disease is poor. Overall median survival is 3-5 months with a 12-month survival rate of 10% and a 5-year survival rate less than 5%. CASE REPORT: We report a rare case of a long-term survivor (more than 10 years) of metastatic carcinoma of the pancreas tail controlled with subsequent surgical and chemotherapeutic strategies with an acceptable performance status and quality of life. DISCUSSION: This is the fifth case reported in the literature showing that long-term survival may be achieved even in advanced pancreatic cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16998247

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  16 in total

Review 1.  Selection of extreme phenotypes: the role of clinical observation in translational research.

Authors:  José Luis Pérez-Gracia; Alfonso Gúrpide; María Gloria Ruiz-Ilundain; Carlos Alfaro Alegría; Ramon Colomer; Jesús García-Foncillas; Ignacio Melero Bermejo
Journal:  Clin Transl Oncol       Date:  2010-03       Impact factor: 3.405

Review 2.  Radiofrequency ablation for unresectable locally advanced pancreatic cancer: a systematic review.

Authors:  Samira Fegrachi; Marc G Besselink; Hjalmar C van Santvoort; Richard van Hillegersberg; Izaak Quintus Molenaar
Journal:  HPB (Oxford)       Date:  2013-04-18       Impact factor: 3.647

3.  Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma with synchronous liver metastasis after treatment with FOLFIRINOX.

Authors:  Kentaro Ozaki; Hiromitsu Hayashi; Yoshiaki Ikuta; Toshiro Masuda; Shinichi Akaboshi; Kenichi Ogata; Katsutaka Matumoto; Katsuhiro Ogawa; Takihiro Kamio; Hideo Baba; Hiroshi Takamori
Journal:  Clin J Gastroenterol       Date:  2019-04-15

4.  Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance.

Authors:  Yu-Zheng Xue; Ying-Yue Sheng; Zong-Liang Liu; Zhe-Qiang Wei; Hai-Yan Cao; Yan-Min Wu; Yu-Feng Lu; Li-Hua Yu; Jian-Ping Li; Zhao-Shen Li
Journal:  Tumour Biol       Date:  2012-12-18

5.  Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer.

Authors:  Kai-Xing Ai; Lin-Yuan Lu; Xin-Yu Huang; Wei Chen; Hui-Zhen Zhang
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

6.  Rare long-term survivors of pancreatic adenocarcinoma without curative resection.

Authors:  Stephen Y Oh; Alicia Edwards; Margaret T Mandelson; Bruce Lin; Russell Dorer; W Scott Helton; Richard A Kozarek; Vincent J Picozzi
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

Review 7.  Surgery for oligometastasis of pancreatic cancer.

Authors:  Fengchun Lu; Katherine E Poruk; Matthew J Weiss
Journal:  Chin J Cancer Res       Date:  2015-08       Impact factor: 5.087

8.  Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival.

Authors:  Lucie Oberic; Frédéric Viret; Charlotte Baey; Marc Ychou; Jaafar Bennouna; Antoine Adenis; Didier Peiffert; Françoise Mornex; Jean-Pierre Pignon; Patrice Celier; Jocelyne Berille; Michel Ducreux
Journal:  Radiat Oncol       Date:  2011-09-26       Impact factor: 3.481

9.  Identification of pancreatic cancer invasion-related proteins by proteomic analysis.

Authors:  Naomi Walsh; Norma O'Donovan; Susan Kennedy; Michael Henry; Paula Meleady; Martin Clynes; Paul Dowling
Journal:  Proteome Sci       Date:  2009-02-14       Impact factor: 2.480

10.  Alterations in integrin expression modulates invasion of pancreatic cancer cells.

Authors:  Naomi Walsh; Martin Clynes; John Crown; Norma O'Donovan
Journal:  J Exp Clin Cancer Res       Date:  2009-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.